ALLO
Allogene Therapeutics Inc
1.50$
-3.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +43.1% | +235.1% | +50.9% | +37.8% | +36.7% | -0.7% | -3.9% | -9.4% | |
| – | – | +148.1% | +41.7% | +23.8% | +3.4% | -21.1% | -21.5% | -27.3% | |
| – | -13.7% | -59.5% | +31.8% | +16.8% | +16.4% | – | – | – | |
| – | +50,300.0% | -156.9% | – | -159.5% | – | -513.0% | – | – | |
| – | -39.3% | +1,470.5% | +29.9% | -67.5% | -75.8% | -70.8% | -54.2% | -44.4% | |
| – | +0.0% | – | -407.8% | – | -35.1% | +53.8% | -53.6% | +26.3% | |
| – | – | -99.7% | +59.5% | +27.2% | -32.0% | +0.0% | -37.6% | -41.7% | |
| – | +0.0% | – | – | – | – | – | – | – | |
| – | +0.0% | -92.4% | +974.6% | -98.1% | -75.3% | +3,143.9% | +21.9% | -74.2% | |
| – | +0.0% | -8.6% | -84.4% | -168.7% | – | – | -137.3% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.